Protocol for assessing whether cognition of preterm infants <29 weeks’ gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trial

INTRODUCTION: Docosahexaenoic acid (DHA) is an omega-3 (n-3) fatty acid that accumulates into neural tissue during the last trimester of pregnancy, as the fetal brain is undergoing a growth spurt. Infants born <29 weeks’ gestation are deprived the normal in utero supply of DHA during this period...

Descripción completa

Detalles Bibliográficos
Autores principales: Gould, Jacqueline F, Makrides, Maria, Sullivan, Thomas R, Anderson, Peter J, Gibson, Robert A, Best, Karen P, McPhee, Andrew J, Doyle, Lex William, Opie, Gillian, Travadi, Javeed, Cheong, Jeanie, Davis, Peter G, Sharp, Mary, Simmer, Karen, Collins, Carmel T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Paediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925903/
https://www.ncbi.nlm.nih.gov/pubmed/33550243
http://dx.doi.org/10.1136/bmjopen-2020-041597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925903/
https://www.ncbi.nlm.nih.gov/pubmed/33550243
http://dx.doi.org/10.1136/bmjopen-2020-041597

Ejemplares similares